Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

158.89
BATS BZX Real-Time Price
As of 10:05am ET
 +3.74 / +2.41%
Today’s Change
113.66
Today|||52-Week Range
178.25
+6.03%
Year-to-Date

Today’s Trading

Previous close155.15
Today’s open154.62
Day’s range154.62 - 159.07
Volume26,040
Average volume (3 months)1,675,665
Market cap$44.8B
Data as of 10:05am ET, 04/26/2018

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+56.34%
Earnings growth (next 5 years)+46.15%
Revenue growth (last year)+46.20%
P/E ratio151.4
Price/Sales15.25
Price/Book22.00

Competitors

 Today’s
change
Today’s
% change
SHPGShire+2.99+1.89%
BAXBaxter International...+2.69+4.04%
ALXNAlexion Pharmaceutic...+6.78+6.39%
ZTSZoetis Inc+0.09+0.11%
Data as of 10:05am ET, 04/26/2018

Financials

Next reporting dateApril 27, 2018
EPS forecast (this quarter)$0.59
Annual revenue (last year)$2.5B
Annual profit (last year)$263.2M
Net profit margin10.58%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Jeffrey M. Leiden
Chief Operating Officer &
Executive Vice President
Ian F. Smith
Corporate headquarters
Boston, Massachusetts

Forecasts